Assenagon Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-36,254
| Closed | -$1.05M | – | 1431 |
|
|
2023
Q4 | $1.05M | Buy |
+36,254
| New | +$1.05M | ﹤0.01% | 1048 |
|
|
2023
Q2 | – | Sell |
-54,889
| Closed | -$1.99M | – | 1411 |
|
|
2023
Q1 | $1.99M | Sell |
54,889
-113,121
| -67% | -$4.1M | 0.01% | 816 |
|
|
2022
Q4 | $5.99M | Buy |
168,010
+125,795
| +298% | +$4.49M | 0.02% | 469 |
|
|
2022
Q3 | $1.43M | Hold |
42,215
| – | – | 0.01% | 802 |
|
|
2022
Q2 | $1.22M | Buy |
+42,215
| New | +$1.22M | ﹤0.01% | 985 |
|
|
2022
Q1 | – | Sell |
-69,389
| Closed | -$2.02M | – | 1498 |
|
|
2021
Q4 | $2.02M | Buy |
+69,389
| New | +$2.02M | 0.01% | 784 |
|
|
2019
Q1 | – | Sell |
-6,702
| Closed | -$223K | – | 1067 |
|
|
2018
Q4 | $223K | Buy |
+6,702
| New | +$223K | ﹤0.01% | 906 |
|